Cargando…

Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution

OBJECTIVE: Use of a catheter lock solution plays a decisive role in vascular access. The effects of different concentrations of heparin and different types of catheter lock solutions are controversial. Therefore, this study aimed to compare the efficacy and safety of sodium citrate and sodium hepari...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, He-ming, Jiang, Xin, Meng, Ling-bing, Di, Chen-yi, Guo, Peng, Qiu, Yong, Dai, Ya-lun, Lv, Xian-qiang, Shi, Chang-jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753535/
https://www.ncbi.nlm.nih.gov/pubmed/31304818
http://dx.doi.org/10.1177/0300060519859143
_version_ 1783452907672174592
author Huang, He-ming
Jiang, Xin
Meng, Ling-bing
Di, Chen-yi
Guo, Peng
Qiu, Yong
Dai, Ya-lun
Lv, Xian-qiang
Shi, Chang-jin
author_facet Huang, He-ming
Jiang, Xin
Meng, Ling-bing
Di, Chen-yi
Guo, Peng
Qiu, Yong
Dai, Ya-lun
Lv, Xian-qiang
Shi, Chang-jin
author_sort Huang, He-ming
collection PubMed
description OBJECTIVE: Use of a catheter lock solution plays a decisive role in vascular access. The effects of different concentrations of heparin and different types of catheter lock solutions are controversial. Therefore, this study aimed to compare the efficacy and safety of sodium citrate and sodium heparin catheter lock solutions. METHODS: A total of 120 patients were divided into four groups (30 patients per group) according to the use of catheter lock solution as follows: 6250 U/mL sodium heparin, 5000 U/mL sodium heparin, 2500 U/mL sodium heparin, and 4% sodium citrate. Coagulation function and the incidence of catheter occlusion, hemorrhage, and catheter-related infections were recorded. RESULTS: The different catheter lock solutions were significantly related to conduit blockage, hemorrhage, infection, and leakage levels. In the 4% sodium citrate group, the odds ratio was 0.688 for conduit blockage (95% confidence interval [CI], 0.206–2.297), 0.286 for hemorrhage (95% CI, 0.091–0.899), 0.266 for infection (95% CI, 0.073–0.964), and 0.416 for leakage (95% CI, 0.141–1.225) compared with the 6250 U/mL sodium heparin. CONCLUSIONS: The solution 4% sodium citrate can effectively reduce the risk of catheter obstruction, bleeding, infection, and leakage better than sodium heparin in patients with long-term intravenous indwelling catheters.
format Online
Article
Text
id pubmed-6753535
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-67535352019-09-25 Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution Huang, He-ming Jiang, Xin Meng, Ling-bing Di, Chen-yi Guo, Peng Qiu, Yong Dai, Ya-lun Lv, Xian-qiang Shi, Chang-jin J Int Med Res Clinical Research Reports OBJECTIVE: Use of a catheter lock solution plays a decisive role in vascular access. The effects of different concentrations of heparin and different types of catheter lock solutions are controversial. Therefore, this study aimed to compare the efficacy and safety of sodium citrate and sodium heparin catheter lock solutions. METHODS: A total of 120 patients were divided into four groups (30 patients per group) according to the use of catheter lock solution as follows: 6250 U/mL sodium heparin, 5000 U/mL sodium heparin, 2500 U/mL sodium heparin, and 4% sodium citrate. Coagulation function and the incidence of catheter occlusion, hemorrhage, and catheter-related infections were recorded. RESULTS: The different catheter lock solutions were significantly related to conduit blockage, hemorrhage, infection, and leakage levels. In the 4% sodium citrate group, the odds ratio was 0.688 for conduit blockage (95% confidence interval [CI], 0.206–2.297), 0.286 for hemorrhage (95% CI, 0.091–0.899), 0.266 for infection (95% CI, 0.073–0.964), and 0.416 for leakage (95% CI, 0.141–1.225) compared with the 6250 U/mL sodium heparin. CONCLUSIONS: The solution 4% sodium citrate can effectively reduce the risk of catheter obstruction, bleeding, infection, and leakage better than sodium heparin in patients with long-term intravenous indwelling catheters. SAGE Publications 2019-07-15 2019-09 /pmc/articles/PMC6753535/ /pubmed/31304818 http://dx.doi.org/10.1177/0300060519859143 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Clinical Research Reports
Huang, He-ming
Jiang, Xin
Meng, Ling-bing
Di, Chen-yi
Guo, Peng
Qiu, Yong
Dai, Ya-lun
Lv, Xian-qiang
Shi, Chang-jin
Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution
title Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution
title_full Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution
title_fullStr Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution
title_full_unstemmed Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution
title_short Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution
title_sort reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution
topic Clinical Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753535/
https://www.ncbi.nlm.nih.gov/pubmed/31304818
http://dx.doi.org/10.1177/0300060519859143
work_keys_str_mv AT huangheming reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution
AT jiangxin reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution
AT menglingbing reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution
AT dichenyi reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution
AT guopeng reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution
AT qiuyong reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution
AT daiyalun reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution
AT lvxianqiang reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution
AT shichangjin reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution